SMS Lifesciences [SMSLIFE] vs Panacea Biotec [PANACEABIO] Detailed Stock Comparison

SMS Lifesciences India Ltd.

NSE
Loading...

Panacea Biotec Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: SMS Lifesciences India Ltd. wins in 15 metrics, Panacea Biotec Ltd. wins in 4 metrics, with 0 ties. SMS Lifesciences India Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric SMS Lifesciences India Ltd. Panacea Biotec Ltd. Better
P/E Ratio (TTM) 22.32 182.62 SMS Lifesciences India Ltd.
Price-to-Book Ratio 2.02 2.65 SMS Lifesciences India Ltd.
Debt-to-Equity Ratio 31.37 2.79 Panacea Biotec Ltd.
PEG Ratio 0.73 -15.02 SMS Lifesciences India Ltd.
EV/EBITDA 11.16 -65.87 SMS Lifesciences India Ltd.
Profit Margin (TTM) 5.54% -1.29% SMS Lifesciences India Ltd.
Operating Margin (TTM) 11.90% 1.99% SMS Lifesciences India Ltd.
EBITDA Margin (TTM) 11.90% 1.99% SMS Lifesciences India Ltd.
Return on Equity 8.99% -1.01% SMS Lifesciences India Ltd.
Return on Assets (TTM) 4.83% -0.65% SMS Lifesciences India Ltd.
Free Cash Flow (TTM) $187.06M $-776.74M SMS Lifesciences India Ltd.
Dividend Yield 0.12% N/A N/A
1-Year Return 21.27% 18.85% SMS Lifesciences India Ltd.
Price-to-Sales Ratio (TTM) 1.24 3.61 SMS Lifesciences India Ltd.
Enterprise Value $5.01B $19.26B Panacea Biotec Ltd.
EV/Revenue Ratio 1.49 3.18 SMS Lifesciences India Ltd.
Gross Profit Margin (TTM) 40.59% 58.88% Panacea Biotec Ltd.
Revenue per Share (TTM) $1,117 $99 SMS Lifesciences India Ltd.
Earnings per Share (Diluted) $61.83 $-1.28 SMS Lifesciences India Ltd.
Beta (Stock Volatility) 0.31 0.14 Panacea Biotec Ltd.

SMS Lifesciences India Ltd. vs Panacea Biotec Ltd. Stock Performance Analysis

Loading Price Chart...

SMSLIFE
PANACEABIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
SMS Lifesciences India Ltd.0.22%-0.12%-16.80%11.43%1.40%7.34%
Panacea Biotec Ltd.0.90%-2.19%39.94%70.71%51.42%43.20%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
SMS Lifesciences India Ltd.21.27%166.25%113.13%893.43%893.43%893.43%
Panacea Biotec Ltd.18.85%307.76%44.67%440.21%276.43%141.23%

Performance & Financial Health Analysis: SMS Lifesciences India Ltd. vs Panacea Biotec Ltd.

MetricSMSLIFEPANACEABIO
Market Information
Market Cap i₹3.58B₹21.84B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i550168,211
90 Day Avg. Volume i1,885144,184
Last Close₹1,406.20₹540.80
52 Week Range₹1,067.00 - ₹1,774.00₹292.40 - ₹647.00
% from 52W High-20.73%-16.41%
All-Time High₹1,774.00 (May 11, 2026)₹647.00 (Jun 09, 2026)
% from All-Time High-20.73%-16.41%
Growth Metrics
Quarterly Revenue Growth0.04%0.01%
Quarterly Earnings Growth0.31%-0.12%
Financial Health
Profit Margin (TTM) i0.06%-0.01%
Operating Margin (TTM) i0.12%0.02%
Return on Equity (TTM) i0.09%-0.01%
Debt to Equity (MRQ) i31.372.79
Cash & Liquidity
Book Value per Share (MRQ)₹682.92₹134.77
Cash per Share (MRQ)₹5.20₹13.86
Operating Cash Flow (TTM) i₹457.63M₹-1,511,860,000
Levered Free Cash Flow (TTM) i₹221.55M₹-83,700,000
Dividends
Last 12-Month Dividend Yield i0.12%N/A
Last 12-Month Dividend i₹1.50₹0.00

Valuation & Enterprise Metrics Analysis: SMS Lifesciences India Ltd. vs Panacea Biotec Ltd.

MetricSMSLIFE (Jan 31, 2026)PANACEABIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i22.32182.62
Forward P/E iN/AN/A
PEG Ratio i0.73-15.02
Price to Sales (TTM) i1.243.61
Price to Book (MRQ) i2.022.65
Market Capitalization
Market Capitalization i₹3.58B₹21.84B
Enterprise Value i₹5.01B₹19.26B
Enterprise Value Metrics
Enterprise to Revenue i1.493.18
Enterprise to EBITDA i11.16-65.87
Risk & Other Metrics
Beta i0.310.14
Book Value per Share (MRQ) i₹682.92₹134.77

Financial Statements Comparison: SMS Lifesciences India Ltd. vs Panacea Biotec Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSMSLIFE (2025)PANACEABIO (2025)
Revenue/Sales i3.37B4.93B
Cost of Goods Sold i2.20B2.36B
COGS % of Revenue i65.2%47.9%
Gross Profit i1.17B2.57B
Gross Margin i34.8%52.1%
Research & Development iN/AN/A
Operating Income (EBIT) i301.28M-556.12M
Operating Margin i8.9%-11.3%
EBITDA i496.13M-76.28M
EBITDA Margin i14.7%-1.5%
Pre-Tax Income i261.90M-79.48M
Pre-Tax Income % of Revenue i7.8%-1.6%
Income Tax i74.58M7.71M
Income Tax % of Revenue i2.2%0.2%
Net Income (Profit) i187.32M-87.19M
Profit Margin i5.6%-1.8%

Balance Sheet & Liquidity Metrics

MetricSMSLIFE (2025)PANACEABIO (2025)
Cash & Equivalents i5.03M821.25M
Total Current Assets i1.51B5.45B
Total Current Assets % of Revenue i44.7%110.7%
Total Current Liabilities i1.42B3.67B
Total Current Liabilities % of Revenue i42.2%74.5%
Long-Term Debt i200.07M150.00M
Long-Term Debt % of Revenue i5.9%3.0%
Total Shareholders Equity i2.12B8.31B
Retained Earnings i1.13B7.80B
Retained Earnings % of Revenue i33.6%158.3%
Property, Plant & Equipment i36.88M5.43B

Cash Flow Statement Comparison

MetricSMSLIFE (2025)PANACEABIO (2025)
Operating Cash Flow i289.74M-1.51B
Operating Cash Flow % of Revenue i8.6%-30.7%
Capital Expenditures i-149.82M-497.30M
Free Cash Flow i187.06M-776.74M
FCF Margin i5.6%-15.8%
Debt Repayment i-178.00M0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSMSLIFEPANACEABIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i3.02M61.25M
Float Shares i639,97215.42M
% Held by Insiders i74.01%72.65%
% Held by Institutions i0.00%0.13%
% Held by Public i25.99%27.22%

Dividend Analysis & Yield Comparison: SMS Lifesciences India Ltd. vs Panacea Biotec Ltd.

MetricSMSLIFEPANACEABIO
Last 12-Month Dividend i₹1.50₹0.00
Last 12-Month Dividend Yield i0.12%N/A
3-Year Avg Annual Dividend i₹1.50₹0.00
3-Year Avg Dividend Yield i0.17%N/A
3-Year Total Dividends i₹4.50₹0.00
Ex-Dividend DateSep 24, 2025N/A